Lercanidipina Alter (Lercanidipine Hydrochloride)

Lercanidipine selectively inhibits L‑type calcium channels in vascular smooth‑muscle cells, preventing calcium‑induced contraction. This causes arterial relaxation, decreases peripheral vascular resistance, and ultimately lowers systemic blood pressure. Its high lipophilicity provides a prolonged duration of action suitable for once‑daily dosing.

The appropriate dose of Lercanidipina Alter is determined by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and any concomitant medications. Dosage adjustments may be required for special populations, and patients should follow the prescriber’s instructions precisely.

Safety of lercanidipine in pregnancy and lactation has not been fully established. It should be used only if the potential benefit justifies the possible risk to the fetus or infant. Healthcare providers must evaluate individual circumstances before prescribing to pregnant or nursing women.

To request Lercanidipina Alter, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Both lercanidipine and amlodipine belong to the dihydropyridine class of calcium‑channel blockers and lower blood pressure by vasodilation. Lercanidipine is more lipophilic, which may result in a longer half‑life and once‑daily dosing, while amlodipine has a well‑established safety profile. Choice of agent depends on clinical judgment, patient tolerance, and drug‑interaction considerations.

Lercanidipina Alter should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and direct sunlight. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Lercanidipina Alter is taken orally, usually once daily, with or without food as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed, unless otherwise instructed.

Serious adverse events, although rare, include angioedema, severe hypotension, and hepatic dysfunction. Patients should seek immediate medical attention if they experience swelling of the face or throat, a sudden drop in blood pressure with fainting, or signs of liver injury such as jaundice or dark urine.

Lercanidipina Alter is contraindicated in patients with known hypersensitivity to lercanidipine or any component of the formulation. Caution is also advised for individuals with severe hepatic impairment, unstable angina, or those taking interacting medications that could precipitate dangerous hypotension.